Read + Share
Amedeo Smart
Independent Medical Education
Koszegi B, Wilson A, Stone C, Satge F, et al. Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: a 30-month experience. Clin Exp Dermatol 2023;48:1266-1269.PMID: 37434310
Email
LinkedIn
Facebook
Twitter
Privacy Policy